These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18171618)

  • 41. Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.
    Mendes TC; Raimundo JM; Nascimento-Junior NM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Pharmacol Biochem Behav; 2009 Nov; 94(1):70-4. PubMed ID: 19635495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.
    Comelli F; Giagnoni G; Bettoni I; Colleoni M; Costa B
    Phytother Res; 2008 Aug; 22(8):1017-24. PubMed ID: 18618522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benzazepinone Nav1.7 blockers: potential treatments for neuropathic pain.
    Hoyt SB; London C; Ok H; Gonzalez E; Duffy JL; Abbadie C; Dean B; Felix JP; Garcia ML; Jochnowitz N; Karanam BV; Li X; Lyons KA; McGowan E; Macintyre DE; Martin WJ; Priest BT; Smith MM; Tschirret-Guth R; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6172-7. PubMed ID: 17889534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms.
    Padi SS; Kulkarni SK
    Eur J Pharmacol; 2008 Dec; 601(1-3):79-87. PubMed ID: 18952075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs.
    Martini E; Di Cesare Mannelli L; Bartolucci G; Bertucci C; Dei S; Ghelardini C; Guandalini L; Manetti D; Scapecchi S; Teodori E; Romanelli MN
    J Med Chem; 2011 Apr; 54(7):2512-6. PubMed ID: 21381762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy.
    Daemen MA; Hoogland G; Cijntje JM; Spincemaille GH
    Neurosci Lett; 2008 Oct; 444(1):112-5. PubMed ID: 18694804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential regulation of TRP channels in a rat model of neuropathic pain.
    Staaf S; Oerther S; Lucas G; Mattsson JP; Ernfors P
    Pain; 2009 Jul; 144(1-2):187-99. PubMed ID: 19446956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective neuropathic pain relief through sciatic nerve administration of GAD65-expressing rAAV2.
    Kim J; Kim SJ; Lee H; Chang JW
    Biochem Biophys Res Commun; 2009 Oct; 388(1):73-8. PubMed ID: 19643087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy with flupirtine and opioid: studies in rat pain models.
    Goodchild CS; Kolosov A; Tucker AP; Cooke I
    Pain Med; 2008 Oct; 9(7):928-38. PubMed ID: 18950446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy.
    Sacerdote P; Franchi S; Trovato AE; Valsecchi AE; Panerai AE; Colleoni M
    Neurosci Lett; 2008 May; 436(2):210-3. PubMed ID: 18394803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain.
    Roh DH; Kim HW; Yoon SY; Seo HS; Kwon YB; Kim KW; Han HJ; Beitz AJ; Na HS; Lee JH
    Anesthesiology; 2008 Nov; 109(5):879-89. PubMed ID: 18946301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists.
    Buck IM; Black JW; Cooke T; Dunstone DJ; Gaffen JD; Griffin EP; Harper EA; Hull RA; Kalindjian SB; Lilley EJ; Linney ID; Low CM; McDonald IM; Pether MJ; Roberts SP; Shankley NP; Shaxted ME; Steel KI; Sykes DA; Tozer MJ; Watt GF; Walker MK; Wright L; Wright PT
    J Med Chem; 2005 Nov; 48(22):6803-12. PubMed ID: 16250639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of 1-arylmethyl-3- (2-aminoethyl)-5-aryluracil as novel gonadotropin-releasing hormone receptor antagonists.
    Zhu YF; Gross TD; Guo Z; Connors PJ; Gao Y; Tucci FC; Struthers RS; Reinhart GJ; Saunders J; Chen TK; Killam Bonneville AL; Chen C
    J Med Chem; 2003 May; 46(11):2023-6. PubMed ID: 12747774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain.
    Bonifacino T; Micheli L; Torazza C; Ghelardini C; Farina C; Bonanno G; Milanese M; Di Cesare Mannelli L; Scherz MW
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anti-amnestic activities of 3-hydroxy-3-pyrroline-2-one derivatives].
    Shuklina NS; Kolla VE
    Eksp Klin Farmakol; 2003; 66(6):12-5. PubMed ID: 14743703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers.
    Pinza M; Farina C; Cerri A; Pfeiffer U; Riccaboni MT; Banfi S; Biagetti R; Pozzi O; Magnani M; Dorigotti L
    J Med Chem; 1993 Dec; 36(26):4214-20. PubMed ID: 8277504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.
    Scapecchi S; Martini E; Manetti D; Ghelardini C; Martelli C; Dei S; Galeotti N; Guandalini L; Novella Romanelli M; Teodori E
    Bioorg Med Chem; 2004 Jan; 12(1):71-85. PubMed ID: 14697772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural products evaluated in neuropathic pain models - a systematic review.
    Quintans JS; Antoniolli AR; Almeida JR; Santana-Filho VJ; Quintans-Júnior LJ
    Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):442-50. PubMed ID: 24252102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and optimization of imidazole derivatives as potent CXCR3 antagonists.
    Du X; Chen X; Mihalic JT; Deignan J; Duquette J; Li AR; Lemon B; Ma J; Miao S; Ebsworth K; Sullivan TJ; Tonn G; Collins TL; Medina JC
    Bioorg Med Chem Lett; 2008 Jan; 18(2):608-13. PubMed ID: 18063364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned.
    Keppel Hesselink JM
    Drug Dev Res; 2017 Mar; 78(2):75-80. PubMed ID: 28195646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.